Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2022-09-06 00:00:00 ET · period of report 2022-09-01 · accession 0001415889-22-009353 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-09-06 | 2022-07-15 | KNSA | Moat Ross | Chief COMMERCIAL Off | A - Grant | $9.56 | +360 | 7,732 | +5% | +$3,442 |
| D | 2022-09-06 | 2022-09-02 | KNSA | Moat Ross | Chief COMMERCIAL Off | M - OptEx | — | +995 | 8,727 | +13% | — |
| D | 2022-09-06 | 2022-09-02 | KNSA | Moat Ross | Chief COMMERCIAL Off | F - Tax | $11.44 | -563 | 8,164 | -6% | -$6,441 |
| D | 2022-09-06 | 2022-09-02 | KNSA | Moat Ross | Chief COMMERCIAL Off | M - OptEx | $0.00 | -995 | 2,982 | -25% | $0 |
| DM | 2022-09-06 | 2022-09-01 | KNSA | Moat Ross | Chief COMMERCIAL Off | A - Grant | $0.00 | +69.4K | 59.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Share | 2022-07-15 | A | A | 360 | $9.56 | 7,732 | D | — | — | |
| 2 | Common | Class A Common Share | 2022-09-02 | M | A | 995 | — | 8,727 | D | — | — | (F2) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. |
| 3 | Common | Class A Common Share | 2022-09-02 | F | D | 563 | $11.44 | 8,164 | D | — | — | |
| 4 | Derivative | Restricted Share Unit | 2022-09-02 | M | D | 995 | $0.00 | 2,982 | D | — · — to — | 995 Class A Common Share | (F2) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. (F5) The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 2, 2021. |
| 5 | Derivative | Restricted Share Unit | 2022-09-01 | A | A | 9,908 | $0.00 | 9,908 | D | — · — to — | 9,908 Class A Common Share | (F2) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. (F4) The RSUs vest over a four year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2022. |
| 6 | Derivative | Share Option | 2022-09-01 | A | A | 59,460 | $0.00 | 59,460 | D | $11.97 · — to 2032-08-31 | 59,460 Class A Common Share | (F3) The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2022. |